[1]
Budnik, I.A., Morozova, O.L., Tsymbal, A.A., Shenkman, B. and Einav, Y. 2017. Effects of fibrinogen concentrate, factor XIII, and thrombin-activatable fibrinolysis inhibitor on clot firmness and fibrinolytic resistance in the model of hyperfibrinolysis. Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 61, 4 (Dec. 2017), 44–50. DOI:https://doi.org/10.25557/IGPP.2017.4.8522.